September 2026

Regulatory Approvals

FDA Approves sNDA for Taletrectinib in ROS1+ NSCLC

Sep 17, 2026

FDA Approves sNDA for Taletrectinib in ROS1+ NSCLC Oncology Nursing News

Regulatory Approvals

FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease

Sep 17, 2026

FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease STAT

Regulatory Approvals

Ultragenyx Stock Jumps on Landmark FDA Approval

Sep 17, 2026

Ultragenyx Stock Jumps on Landmark FDA Approval Barron's

Regulatory Approvals

FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A

Sep 17, 2026

The U.S. Food and Drug Administration today approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type…

Credit Ratings

BHP captive stops writing new business as Fitch affirms ratings

Sep 17, 2026

BHP captive stops writing new business as Fitch affirms ratings Captive Insurance Times

September 2026

FDA Approves sNDA for Taletrectinib in ROS1+ NSCLC

FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease

Ultragenyx Stock Jumps on Landmark FDA Approval

FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A

BHP captive stops writing new business as Fitch affirms ratings

Financial News For All

Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer

FDA Approves Ryzumvi Eye Drops for Presbyopia

Haemonetics says FDA clears vascular closure device

FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery